What Is Central Sleep Apnea?

Key Takeaways

• Central sleep apnea occurs when the brain temporarily stops sending breathing signals to the respiratory muscles during sleep.
• What causes central sleep apnea varies: heart failure, opioid medications, stroke, and high altitude are the most common triggers.
• Is central sleep apnea dangerous? Yes. It's associated with higher cardiovascular risk, oxygen desaturation, and increased mortality compared to obstructive sleep apnea.
• Standard CPAP is not the first-line treatment for central sleep apnea. Adaptive servo-ventilation (ASV) or bilevel positive airway pressure (BiPAP) is typically used.
• Treating the underlying condition (heart failure, medication adjustment, neurological issues) is often the most effective approach.

What Is Central Sleep Apnea and How Is It Different?

The brain-driven mechanism

What is central sleep apnea at a physiological level? During normal sleep, your brainstem automatically regulates breathing by monitoring blood CO2 levels and sending rhythmic signals to your diaphragm and respiratory muscles. In central sleep apnea, this automatic control temporarily fails.

The result is a cessation of breathing effort. Your chest doesn't rise. Your diaphragm doesn't contract. Air doesn't flow. This pause typically lasts 10-30 seconds before the brain "resets" and breathing resumes, often with a gasp or deep breath.

Central vs. obstructive: the key distinction

In obstructive sleep apnea (OSA), you're trying to breathe but can't because the airway is physically blocked. Your chest and diaphragm strain against the obstruction. In central sleep apnea, there's no effort at all. The airway is open, but nothing is pushing air through it.

This distinction matters enormously for treatment. Strategies that work for obstructive sleep apnea, like weight loss, positional therapy, and oral appliances, don't address the central nervous system dysfunction underlying CSA. Some people have both types simultaneously, called complex or mixed sleep apnea.

What Causes Central Sleep Apnea?

Heart failure: the most common cause

What causes central sleep apnea most frequently? Heart failure. Up to 40% of people with heart failure develop a form of CSA called Cheyne-Stokes respiration, characterized by a crescendo-decrescendo breathing pattern. As the heart's pumping ability weakens, circulation time between the lungs and brain increases, creating a feedback delay in CO2 monitoring that destabilizes breathing control.

A study in the Journal of the American College of Cardiology found that CSA in heart failure patients is an independent predictor of worse outcomes, making it both a symptom and an accelerant of cardiac decline.

Opioid-induced central sleep apnea

Opioid medications (morphine, oxycodone, methadone, fentanyl) suppress the brainstem's respiratory drive. Chronic opioid use is associated with central sleep apnea in up to 30% of patients on long-term therapy. The risk increases with higher doses and longer duration of use.

This type of CSA is particularly concerning because it can cause prolonged apneas with significant oxygen desaturation. If you're on chronic opioid therapy and experience disrupted sleep, fatigue, or low oxygen levels during sleep, talk to your doctor about screening.

Neurological conditions

Conditions that damage the brainstem or its connections can cause central sleep apnea. These include stroke (particularly brainstem strokes), brain tumors, encephalitis, neurodegenerative diseases like Parkinson's, and spinal cord injuries. The common thread is disruption of the neural circuitry that controls automatic breathing.

High-altitude central sleep apnea

At high altitude, lower oxygen levels trigger hyperventilation, which reduces blood CO2 below the "apneic threshold." When CO2 drops too low, the brain stops sending breathing signals until CO2 builds back up. This creates the periodic breathing pattern familiar to mountaineers and visitors to high-altitude locations. It typically resolves when you return to lower elevation.

Treatment-emergent central sleep apnea

Some people develop central apnea events after starting CPAP therapy for obstructive sleep apnea. This "complex sleep apnea" occurs in about 5-15% of OSA patients initiating CPAP. In many cases, it resolves within weeks to months as the brain adjusts to the new breathing dynamics.

Is Central Sleep Apnea Dangerous?

Cardiovascular risks

Is central sleep apnea dangerous? The evidence suggests it carries higher risks than obstructive sleep apnea in several ways. Each central apnea event causes oxygen desaturation and sympathetic nervous system activation (the "fight or flight" response). Over time, this repeated cardiovascular stress contributes to:

• Arrhythmias, including atrial fibrillation
• Worsening heart failure
• Hypertension that's resistant to medication
• Heart palpitations and cardiac strain

A study in the Journal of the American College of Cardiology found that heart failure patients with central sleep apnea had significantly higher mortality rates than those without, independent of heart failure severity.

Oxygen desaturation and brain effects

Central apnea events often produce more profound oxygen drops than obstructive events because there's zero breathing effort during the pause. Repeated severe desaturation damages neurons, impairs cognitive function, and accelerates neurodegenerative processes. Daytime cognitive symptoms including poor concentration, memory problems, and brain fog are common.

Impact on quality of life

Is central sleep apnea dangerous beyond the cardiovascular risks? The chronic sleep fragmentation produces debilitating daytime fatigue, mood disturbances, and reduced functional capacity. Many people with CSA report feeling exhausted despite spending adequate time in bed, because the quality of their sleep is severely compromised.

Recognizing the Symptoms

What central sleep apnea looks and feels like

What does central sleep apnea sound like to a bed partner? Unlike obstructive sleep apnea's loud snoring, CSA is often quieter. A partner might notice silent pauses in breathing followed by gasps or sighs, without the crescendo snoring pattern. The breathing may follow a rhythmic waxing-and-waning pattern (Cheyne-Stokes respiration).

Common symptoms include:

• Witnessed breathing pauses during sleep without snoring
• Waking up short of breath or with a sensation of choking
• Excessive daytime sleepiness despite adequate sleep time
• Difficulty staying asleep (frequent awakenings)
• Morning headaches
• Anxiety or mood changes

Why it's often missed

Central sleep apnea lacks the dramatic snoring that sends many obstructive sleep apnea patients to the doctor. People with CSA may not even know they stop breathing at night, especially if they sleep alone. The daytime symptoms (fatigue, cognitive difficulty) are nonspecific and often attributed to stress, aging, or depression.

How Central Sleep Apnea Is Diagnosed

The sleep study is essential

The only way to definitively diagnose central sleep apnea is through a polysomnography study (sleep study). This overnight test monitors brain waves, breathing effort (chest and abdominal movements), airflow, and oxygen saturation simultaneously.

The key diagnostic finding is apnea events without respiratory effort. If the chest and abdomen show no movement during a breathing pause, the event is central rather than obstructive. A central apnea index (CAI) of 5 or more events per hour indicates clinically significant CSA.

Additional testing

Because central sleep apnea is often secondary to another condition, your doctor will likely investigate underlying causes. This may include cardiac evaluation (echocardiogram, BNP levels), neurological assessment, medication review (especially opioids), and blood work to check metabolic and hormonal factors that influence respiratory drive.

Treatment Options for Central Sleep Apnea

Treat the underlying cause first

The most effective approach to central sleep apnea is addressing whatever is causing it. For heart failure patients, optimizing cardiac treatment often reduces CSA severity significantly. For opioid-induced CSA, dose reduction or switching medications may resolve the breathing pattern entirely. For high-altitude CSA, descent or acclimatization is the answer.

Positive airway pressure devices

• Adaptive servo-ventilation (ASV): The gold standard device for most CSA types. ASV monitors your breathing pattern and delivers variable pressure support, backing off when you're breathing normally and increasing support during apneas. Important exception: ASV is contraindicated in heart failure patients with reduced ejection fraction (below 45%) due to increased mortality risk found in the SERVE-HF trial.
• BiPAP with a backup rate: Delivers set breaths if your spontaneous breathing rate drops below a threshold. Useful for opioid-induced and neurological CSA.
• CPAP: Sometimes effective for mild CSA and may be tried first, though it's less effective than ASV for most central apnea types.

Supplemental oxygen

Nocturnal oxygen therapy can reduce central apnea events in some patients, particularly those with heart failure-related CSA. It works by preventing the oxygen desaturation that triggers the arousal-hyperventilation cycle. However, it doesn't address the underlying breathing instability.

Medications

Acetazolamide, a mild diuretic that causes metabolic acidosis, can stimulate respiratory drive and reduce central apnea events at high altitude and in some heart failure patients. Theophylline has also shown benefit in limited studies. Medication options are generally considered second-line after device therapy.

Living With Central Sleep Apnea

Long-term management

Central sleep apnea typically requires ongoing management rather than a one-time fix. Regular follow-up sleep studies help track whether treatment is effective. If you have an underlying condition like heart failure, managing that condition aggressively is the best way to keep CSA under control.

Monitoring your overall health

The systemic effects of central sleep apnea, from cardiovascular strain to metabolic disruption, benefit from regular monitoring. Tracking metabolic indicators, cardiac biomarkers, and inflammatory markers over time helps you and your doctor assess whether your treatment is adequately protecting your body from the downstream consequences of disrupted breathing.

Take the Next Step With Superpower

Central sleep apnea doesn't exist in isolation. It connects to cardiovascular health, neurological function, and metabolic balance in ways that a sleep study alone can't fully capture. Understanding the systemic effects requires looking at the broader picture.

Superpower's at-home blood panel measures 100+ biomarkers spanning cardiovascular, metabolic, inflammatory, and hormonal markers. These give you and your healthcare team a comprehensive view of how central sleep apnea is affecting your body and whether your treatment is working.

Start your Superpower membership today and get the complete picture of your health.